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Julius M. Gardin, MD, MBAC oronary heart disease (CHD) continues to bea major global cause of death and morbidity.Tremendous resources have been invested
in diagnosing CHD and predicting CHD mortality
and morbidity. Although Framingham and other risk
scores have contributed importantly to risk stratiﬁca-
tion of patients with suspected CHD, they are imper-
fect. Consequently, major efforts have been devoted
to investigating the incremental utility of cardiac
noninvasive imaging techniques, serum biomarkers,
and so on, in predicting mortality and morbidity in
patients with suspected CHD.SEE PAGE 389In this issue of iJACC, Gaibazzi, et al. (1) present the
results of a retrospective multicenter transthoracic
echocardiography assessment of the value of an
echocardiographic calcium score (eCS) in addition to
stress-induced left ventricular (LV) wall motion ab-
normalities (WMAs) as detected by exercise or phar-
macological stress echocardiography in predicting
myocardial infarction (MI) and all-cause mortality.
Patients from 6 centers (n ¼ 1,303) were followed for
808 days (median). eCS was assessed as the presence
and/or severity of calcium (scale of 0 to 3) in 4 regions:
the aortic valve, mitral annulus, papillary muscle, and
the ascending aorta. The investigators’ rationale for
evaluating eCS in addition to echocardiographic WMA
is that eCS has been correlated with ischemic stress
echocardiographic results, morbidity, and mortality
(1,2). The investigators used receiver-operating char-
acteristic analysis along with Youden’s index
(YI ¼ sensitivity þ speciﬁcity  1, where a value of 1
denotes a perfect test) to determine the optimal eCS*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
From the Department of Medicine, Hackensack University Medical
Center, Hackensack, New Jersey. Dr. Gardin has reported that he has
no relationships relevant to the contents of this paper to disclose.cutpoint, which, fortuitously, turned out to be eCS>0.
This threshold resulted in a modest sensitivity (74%)
and speciﬁcity (60%) for predicting the study end-
points. In the multivariate analyses, age, diabetes
mellitus, eCS >0, revascularization after 3 months,
and stress echocardiographic WMA were multivariate
predictors of MI or all-cause mortality. Patients with
WMA and eCS >0 demonstrated a 3-year event rate of
24%; those with an eCS ¼ 0 and no WMA demon-
strated a 2% event rate (p < 0.001). When added to
clinical data, both stress WMA and eCS demonstrated
a net reclassiﬁcation improvement (NRI) (continuous
NRI ¼ 0.28 and 0.58, respectively); eCS also demon-
strated an incremental reclassiﬁcation value (NRI ¼
0.58; p < 0.001) over a model that included clinical
parameters andWMA. However, the addition of eCS to
clinical parameters and WMA did not improve the
ability of the model to discriminate between those
who did and did not experience death or MI (Harrell’s
C index: 0.792 vs. 0.784; p ¼ 0.61). Importantly, as the
investigators and others stressed, when the compari-
son model has a high C index (e.g., 0.784), the addi-
tion of a factor such as eCS may improve predictive
accuracy without improving the C index (3).
Strengths of this study include that it demonstrates
the prognostic value of a semiquantitative cardiac
calcium score in patients with suspected CHD.
Noninvasive images for eCS determination can be
obtained easily during the resting segment of a stress
echocardiographic study at modest cost in time and
effort. An eyeball assessment of eCS may be particu-
larly useful when stress echocardiographic images are
suboptimal for assessing WMA.
Weaknesses include that the study was retrospec-
tive, and the population and proportion of pharma-
cological versus exercise stress tests likely differed
among contributing centers. Furthermore, it was not
clear whether eCS and stress echocardiographic read-
ings were performed independently. As noted, the eCS
did not appear to add incrementally to discriminative
ability of events versus nonevents compared with a
combination of clinical markers andWMA assessment.
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398Also, there were few patients with higher calcium
scores (e.g., eCS $4); therefore, the incremental value
of increasing scores could not be evaluated. In addi-
tion, echocardiographic densities may have some-
times represented ﬁbrosis, not calciﬁcation.
Clearly, although addition of eCS to stress echo-
cardiographic WMA analysis may be helpful, it does
not represent a major prognostic breakthrough. The
investigators admit it is unclear how eCS should be
used clinically. It seems advisable, because of this
predominantly negative multicenter clinical study,
to look beyond eCS to other approaches for pre-
dicting CHD endpoints. Well-documented standard
stress echocardiographic predictors of high risk (e.g.,
relative risk $4-fold over low risk) for mortality
and composite cardiac endpoints in known or sus-
pected patients with CHD include extensive rest or
exercise ischemia-induced WMA (involving 4 to 5 LV
segments), multivessel ischemia, baseline LV ejection
fraction <40%, low ischemic threshold, and so on.
(4). Studies that compare radionuclide myocardial
perfusion imaging with stress echocardiography have
demonstrated comparable prognostic value in several
meta-analyses (5).
Other noninvasive approaches have also been used
to predict death and cardiovascular morbid events,
including additions to standard echocardiography
(perfusion imaging and strain and/or strain rate im-
aging), other imaging tests (cardiac magnetic reso-
nance and computed tomographic angiography), and
serum biomarker testing (Table 1). These modalities
exhibit predictive values (expressed as hazards ratios
or relative risks) that exceed that of eCS. Selection of
the most appropriate prognostic test, or test combi-
nation, will depend on factors such as the clinical
question, population characteristics (e.g., pre-test
CHD probability), procedural attributes (e.g., cost),
risk (e.g., radiation, and so on), availability, and
expertise of the operators, as well as other factors.
Additional research, especially head-to-head com-
parisons, should help determine which noninvasive
test, or more likely, “polytest” (analogous to the poly-
pill) will be most useful in a given clinical scenario.
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